Country
Contract Development & Manufacturing Organizations in the United Kingdom
A clinical-stage and cell-&-gene-therapy hub. Compare MHRA-regulated UK CDMOs across biologics, advanced therapies, and drug product — by capability and site.
125 companies listed
Manufacturing sites in United Kingdom
The UK CDMO landscape
The United Kingdom has a distinctive CDMO profile weighted toward clinical-stage manufacturing, biologics, and cell & gene therapy — reflecting its dense academic-biotech ecosystem around the Golden Triangle of Cambridge, Oxford, and London, plus advanced-therapy clusters in Stevenage and the north.
Post-Brexit, UK manufacturing is regulated by the MHRA, which has positioned itself as an agile regulator with recognition routes that ease parallel UK, EU, and US programs. For early-phase and advanced-therapy work, the UK offers a deep pool of specialist capacity and English-language regulatory alignment.
The UK is a particularly strong fit for clinical trial material supply and cell-&-gene-therapy manufacturing, where its concentration of specialist CDMOs and proximity to leading academic centers shortens the path from research to GMP production.
Companies (60)
3Dbiofibr
United Kingdom
7bridges (the7bridges.com)
United Kingdom
AB Biotechnology Ltd
United Kingdom
ABITEC Corporation
United Kingdom
Abzena
United Kingdom
A
adthera bio limited
United Kingdom
A
Advanced Therapies
United Kingdom
Algae Products International Ltd
United Kingdom
Almac Group
United Kingdom
A
AptarGroup Inc
United Kingdom
A
Aptuit LLC
United Kingdom
Argenta (Animal Health CRO/CDMO)
United Kingdom
Arkema
United Kingdom
Arvato (Healthcare)
United Kingdom
Arxada (CDMO)
United Kingdom
A
AS-TEC Chemicals Ltd.
United Kingdom
Asymchem
United Kingdom
Aurigene Services
United Kingdom
Bachem AG
United Kingdom
BAP Pharma
United Kingdom
Bastion Therapeutics Ltd.
United Kingdom
BBI Solutions
United Kingdom
BDD Pharma
United Kingdom
B
Berry Global
United Kingdom
Bespak
United Kingdom
B
Bio‑Techne
United Kingdom
Biofortuna
United Kingdom
BioIVT
United Kingdom
Bionical Emas
United Kingdom
BioReliance (Merck KGaA, MilliporeSigma)
United Kingdom
B
Biosynth
United Kingdom
Biotage AB
United Kingdom
Blue Yonder
United Kingdom
CARBOGEN AMCIS
United Kingdom
Catalent Pharma Solution
United Kingdom
CatSci Ltd
United Kingdom
CATUG (CATUG Biotech)
United Kingdom
CCL Healthcare
United Kingdom
Celerion
United Kingdom
Cell and Gene Therapy Catapult
United Kingdom
Central Pharma Contract Packing Ltd
United Kingdom
C
CEVA Logistics (Healthcare)
United Kingdom
Charles River Laboratories
United Kingdom
Cobra Biologics
United Kingdom
Concept Life Sciences
United Kingdom
Cultech Ltd.
United Kingdom
Custom Pharma Services
United Kingdom
C
Cytiva
United Kingdom
Dishman Carbogen Amcis Ltd
United Kingdom
Douglas CDMO
United Kingdom
EMBALL’ISO
United Kingdom
Eromol UK Ltd (Eramol)
United Kingdom
Ethypharm
United Kingdom
Eurotherm Ltd
United Kingdom
Evotec
United Kingdom
eXmoor Pharma Concepts Ltd
United Kingdom
FabRx Ltd
United Kingdom
Fareva
United Kingdom
F
Flow Eighteen38
United Kingdom
F
FUJIFILM Biotechnologies / FUJIFILM Diosynth
United Kingdom
Frequently Asked Questions
How many CDMOs are in the UK?+
CDMO Hub lists a strong UK roster — the live count and ranked list above are built from verified manufacturing sites, reflecting genuine in-country capacity rather than headquarters alone.
What are UK CDMOs strongest in?+
The UK skews toward clinical-stage manufacturing, biologics, and cell & gene therapy, supported by world-leading academic-biotech clusters. It is an especially strong choice for early-phase and advanced-therapy programs.
How are UK CDMOs regulated after Brexit?+
UK drug manufacturing is regulated by the MHRA. The MHRA operates recognition and aligned routes that facilitate parallel UK, EU, and US development. Confirm the specific facility's approvals for your target markets before contracting.
Find the right CDMO in United Kingdom
Our AI Matchmaker analyzes your project requirements and matches you with qualified United Kingdom manufacturing partners. Free for buyers.